These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 3685380)

  • 21. Antibacterial activity in vitro of sulbenicillin against mucoid and non-mucoid strains of Pseudomonas aeruginosa.
    Eftimiadi C; De Leo C; Schito GC
    Drugs Exp Clin Res; 1985; 11(4):241-5. PubMed ID: 3939120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative bactericidal activity of beta-lactam-aminoglycoside combinations against Pseudomonas aeruginosa].
    Cluzel M; Chanal M; Sirot J; Cluzel R
    Nouv Presse Med; 1982 Nov; 11(46):3400-4. PubMed ID: 6818523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative review of two new wide-spectrum penicillins: mezlocillin and piperacillin.
    Russo J; Russo ME
    Clin Pharm; 1982; 1(3):207-16. PubMed ID: 6224627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of the inoculum concentration on the in vitro sensitivity of Pseudomonas aeruginosa].
    Zarakolu P; Cöplü N; Güvener E
    Mikrobiyol Bul; 1993 Jul; 27(3):211-5. PubMed ID: 8361409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vitro susceptibilities among gram-negative rods.
    Westblom TU; Midkiff BR
    W V Med J; 1989 Jul; 85(7):279-80. PubMed ID: 2756707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Piperacillin and gentamicin v carbenicillin and gentamicin for treatment of serious gram-negative infections.
    Kohler RB; Foerster LA; Wheat LJ; Williams JM; Reynolds J; Norton J
    Arch Intern Med; 1982 Jul; 142(7):1335-7. PubMed ID: 6212035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antimicrobial susceptibility patterns of clinical isolates of Pseudomonas cepacia (author's transl)].
    Igari J; Kosakai N; Oguri T
    Jpn J Antibiot; 1979 Oct; 32(10):998-1002. PubMed ID: 259663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Susceptibilities of Pseudomonas species to aminoglycosides and tetracyclines].
    Igari J; Kosakai N; Oguri T
    Jpn J Antibiot; 1982 May; 35(5):1233-9. PubMed ID: 7131756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the pharmacokinetic and pharmacodynamic activity of piperacillin and mezlocillin.
    Sullivan MC; Nightingale CH; Quintiliani R; Sweeney K
    Pharmacotherapy; 1993; 13(6):607-12. PubMed ID: 8302686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of amikacin, gentamicin and Schering 21420 when combined with carbenicillin or piperacillin against Pseudomonas aeruginosa.
    Schafer F; Norden CW
    Chemotherapy; 1982; 28(4):253-6. PubMed ID: 6214381
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of temperature on antimicrobial susceptibilities of Pseudomonas species isolated from drinking water.
    Papapetropoulou M; Rodopoulou G; Giannoulaki E; Stergiopoulos P
    J Chemother; 1994 Dec; 6(6):404-7. PubMed ID: 7699428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC; Jenkins R; Matsen JM
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centers.
    Barry AL; Jones RN; Ayers LW; Gavan TL; Gerlach EH; Sommers HM
    Antimicrob Agents Chemother; 1984 May; 25(5):669-71. PubMed ID: 6732234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study.
    Gavan TL; Jones RN; Barry AL; Fuchs PC; Gerlach EH; Matsen JM; Reller LB; Thornsberry C; Thrupp LD
    J Clin Microbiol; 1981 Jul; 14(1):67-72. PubMed ID: 6455443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial activity of piperacillin in vitro].
    Skala LZ; Nekhorosheva AG; Nasonov VN; Prokhorova VA
    Antibiot Khimioter; 1991 Aug; 36(8):39-42. PubMed ID: 1755709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of apalcillin against Pseudomonas aeruginosa.
    Hollick GE; Gundrum J; Venezia RA
    Antimicrob Agents Chemother; 1984 Sep; 26(3):408-9. PubMed ID: 6439115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum bactericidal rate as measure of antibiotic interactions.
    Briceland LL; Pasko MT; Mylotte JM
    Antimicrob Agents Chemother; 1987 May; 31(5):679-85. PubMed ID: 3111359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin.
    Lutz B; Mogabgab W; Holmes B; Pollock B; Beville R
    Antimicrob Agents Chemother; 1982 Jul; 22(1):10-4. PubMed ID: 6214992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antimicrobial activity of amiloride analogs against Pseudomonas.
    Cohn RC; Rudzienski L; Putnam RW
    Chemotherapy; 1992; 38(4):232-7. PubMed ID: 1473362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.